View all news

Award for outstanding achievement in life sciences

2 July 2007

An alumna has been honoured for her leadership in developing new vaccines for serious global infectious diseases including cholera, ETEC, typhoid, paratyphoid and rotavirus disease.

An alumna has been honoured for her leadership in developing new vaccines for serious global infectious diseases including cholera, ETEC, typhoid, paratyphoid and rotavirus disease.

Dr Una Ryan (BSc 1963) received the Albert Einstein Award for Outstanding Achievement in the Life Sciences at a special ceremony in Jerusalem on 25 June 2007. The award, given by Global Capital Associates, salutes leaders whose vision and commitment have contributed to the critical advancement of vital life-saving and life-enhancing technology to benefit mankind.

‘I share this honour with colleagues striving to improve healthcare globally through the development of better, more effective vaccines for serious diseases,’ said Dr Ryan.

Former awardees include George Poste, Director of the Biodesign Institute at ArizonaStateUniversity, Francis Collins, Director of the National Human Genome Institute and Jeremy Levin, Head of Research and Development at Novartis.

Dr Ryan is President of AVANT Immunotherapeutics, which discovers and develops innovative vaccines and therapeutics that harness the human immune system to prevent and treat disease.